Assessment of Wound Closure Comparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot Ulcers (DFU) and With Living Cellular Skin Substitute in Treating Venous Leg Ulcers (VLU)

NCT04927702 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

48

Enrollment

INDUSTRY

Sponsor class

Stopped Study was terminated due to slow enrollment

Conditions

Diabetic Foot Ulcer
Venous Leg Ulcer

Interventions

DEVICE: Synthetic Hybrid-Scale Fiber Matrix
DEVICE: Standard of Care
DEVICE: Living Cellular Skin Substitute

Sponsor

Acera Surgical, Inc.